Pacemaker-Mediated Programmable Hypertension Control Therapy.

about

Programmable Hypertension Control: Another Possible Indication for Implanted Pacemakers.

P2860

Q49593539-6B7908F2-13A6-4E27-AD3C-DAAF0D8D7591

P2860

Pacemaker-Mediated Programmable Hypertension Control Therapy.

Item

http://www.wikidata.org/entity/Q47221239

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Pacemaker-Mediated Programmable Hypertension Control Therapy.

@en

Pacemaker-Mediated Programmable Hypertension Control Therapy.

@nl

type

Item

label

Pacemaker-Mediated Programmable Hypertension Control Therapy.

@en

Pacemaker-Mediated Programmable Hypertension Control Therapy.

@nl

prefLabel

Pacemaker-Mediated Programmable Hypertension Control Therapy.

@en

Pacemaker-Mediated Programmable Hypertension Control Therapy.

@nl

P1476

Pacemaker-Mediated Programmable Hypertension Control Therapy.

@en

P2093

Andrejs Erglis

http://www.w3.org/2001/XMLSchema#string

Audrius Aidietis

http://www.w3.org/2001/XMLSchema#string

BackBeat Study Investigators

http://www.w3.org/2001/XMLSchema#string

Béla Merkely

http://www.w3.org/2001/XMLSchema#string

Daniel Burkhoff

http://www.w3.org/2001/XMLSchema#string

Germanas Marinskis

http://www.w3.org/2001/XMLSchema#string

Ginta Kamzola

http://www.w3.org/2001/XMLSchema#string

Herwig Schmidinger

http://www.w3.org/2001/XMLSchema#string

Istvan Osztheimer

http://www.w3.org/2001/XMLSchema#string

Jan Petru

http://www.w3.org/2001/XMLSchema#string

P2860

The Hawthorne Effect: a randomised, controlled trial

New approaches in the treatment of hypertension

The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report

A controlled trial of renal denervation for resistant hypertension

Reduced blood pressure-lowering effect of catheter-based renal denervation in patients with isolated systolic hypertension: data from SYMPLICITY HTN-3 and the Global SYMPLICITY Registry.

Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.

Baroreflex activation therapy provides durable benefit in patients with resistant hypertension: results of long-term follow-up in the Rheos Pivotal Trial.

2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC).

The baroreflex as a long-term controller of arterial pressure.

The acute effects of changes to AV delay on BP and stroke volume: potential implications for design of pacemaker optimization protocols.

P31

scholarly article

P356

10.1161/JAHA.117.006974

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Karl-Heinz Kuck

Joris R de Groot

P577

2017-12-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29275370

http://www.w3.org/2001/XMLSchema#string

P932

5779015

http://www.w3.org/2001/XMLSchema#string

Pacemaker-Mediated Programmable Hypertension Control Therapy.

about

P2860

P2860

Pacemaker-Mediated Programmable Hypertension Control Therapy.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P31

P356

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P31

P356

P433

P478

P50

P577

P698

P932